Catalyst Wire Dossier Catalyst Wire Dossier
EMA withdrawal · 2020-02-18

EMA Withdrawn: Nonafact (human coagulation factor IX) — Sanquin Plasma Products B.V.

View source ↗

Summary

EMA withdrawn the product Nonafact (human coagulation factor IX) for Hemophilia B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nonafact (Factor IX)

Snippet

Status: Withdrawn. Therapeutic area: Hemophilia B. MAH: Sanquin Plasma Products B.V.. Decision date: 24/11/2016